Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide during cardiopulmonary bypass for congenital heart surgery in infants and young children
ACTRN12617000821392Phase 2Completed
- Sponsor
- A/Prof Andreas Schibler
- Start
- Jul 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing Nitric oxide during CPB with Placebo / standard bypass gas (2 arms). Primary endpoint: Ventilator-free days / length of mechanical ventilation. Started Jul 2017; status: completed.
02
Drugs
nitric oxide
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12617000821392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000821392.